SenoRx breast cancer radiation balloon
This article was originally published in The Gray Sheet
Executive Summary
Firm will delay until early 2008 a full launch of its multi-lumen Radiation Balloon breast cancer brachytherapy device following 510(k) clearance, announced May 23. SenoRx plans clinical trials to support marketing claims prior to its debut. The minimally invasive device uses a vacuum to remove excess fluid and keep the balloon adhered to irregularly shaped lumpectomy cavities, and its multiple radiation seed lumens enable precise radiation dosing, SenoRx explains. The Aliso Viejo, Calif. company went public in March (1"The Gray Sheet" April 9, 2007, p. 8)...